Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-07-27

Clinical Trial Update: Comparison of Losartan Associated With Indapamide Versus Hyzaar® in the Hypertension Treatment [Phase 3]

View source ↗

Summary

Phase 3 trial update comparing losartan with indapamide to Hyzaar in hypertension; study status suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hyzaar (losartan/hydrochlorothiazide)

Snippet

Sponsor: EMS | Conditions: Hypertension | Phase 3 | Status: SUSPENDED